These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31259314)

  • 1. Highly Efficient Clinical Trials Simulator (HECT): Software application for planning and simulating platform adaptive trials.
    Thorlund K; Golchi S; Haggstrom J; Mills E
    Gates Open Res; 2019; 3():780. PubMed ID: 31259314
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency.
    Collignon O; Koenig F; Koch A; Hemmings RJ; Pétavy F; Saint-Raymond A; Papaluca-Amati M; Posch M
    Trials; 2018 Nov; 19(1):642. PubMed ID: 30454061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials - an example in hemato-oncology.
    Jacob L; Uvarova M; Boulet S; Begaj I; Chevret S
    BMC Med Res Methodol; 2016 Jun; 16():67. PubMed ID: 27250349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
    Lin J; Bunn V
    Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sceptical priors on the performance of adaptive clinical trials with binary outcomes.
    Granholm A; Lange T; Harhay MO; Perner A; Møller MH; Kaas-Hansen BS
    Pharm Stat; 2024 Mar; ():. PubMed ID: 38553422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A web application for the design of multi-arm clinical trials.
    Grayling MJ; Wason JM
    BMC Cancer; 2020 Jan; 20(1):80. PubMed ID: 32005187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BOIN Suite: A Software Platform to Design and Implement Novel Early-Phase Clinical Trials.
    Zhou Y; Lin R; Kuo YW; Lee JJ; Yuan Y
    JCO Clin Cancer Inform; 2021 Jan; 5():91-101. PubMed ID: 33439726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing Sample Size Allocation and Power in a Bayesian Two-Stage Drop-The-Losers Design.
    Karanevich A; Meier R; Graw S; McGlothlin A; Gajewski B
    Am Stat; 2019; 2019():. PubMed ID: 32981939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.
    Brown AR; Gajewski BJ; Aaronson LS; Mudaranthakam DP; Hunt SL; Berry SM; Quintana M; Pasnoor M; Dimachkie MM; Jawdat O; Herbelin L; Barohn RJ
    Trials; 2016 Aug; 17(1):428. PubMed ID: 27577191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Bayesian response-adaptive trial design for the Dexamethasone for Excessive Menstruation study.
    Holm Hansen C; Warner P; Parker RA; Walker BR; Critchley HO; Weir CJ
    Stat Methods Med Res; 2017 Dec; 26(6):2681-2699. PubMed ID: 26423728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Web-Based Data Collection Platform for Multisite Randomized Behavioral Intervention Trials: Development, Key Software Features, and Results of a User Survey.
    Modi RA; Mugavero MJ; Amico RK; Keruly J; Quinlivan EB; Crane HM; Guzman A; Zinski A; Montue S; Roytburd K; Church A; Willig JH
    JMIR Res Protoc; 2017 Jun; 6(6):e115. PubMed ID: 28623185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian adaptive design for clinical trials of rare efficacy outcomes with multiple definitions.
    Golchi S; Willard JJ; Pullenayegum E; Bassani DG; Pell LG; Thorlund K; Roth DE
    Clin Trials; 2022 Dec; 19(6):613-622. PubMed ID: 36408565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiencies of platform clinical trials: A vision of the future.
    Saville BR; Berry SM
    Clin Trials; 2016 Jun; 13(3):358-66. PubMed ID: 26908536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical guide to pre-trial simulations for Bayesian adaptive trials using SAS and BUGS.
    Hansen CH; Warner P; Walker A; Parker RA; Whitaker L; Critchley HOD; Weir CJ
    Pharm Stat; 2018 Nov; 17(6):854-865. PubMed ID: 30215881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ShinyGPAS: interactive genomic prediction accuracy simulator based on deterministic formulas.
    Morota G
    Genet Sel Evol; 2017 Dec; 49(1):91. PubMed ID: 29262775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian adaptive clinical trials of combination treatments.
    Thorlund K; Golchi S; Mills E
    Contemp Clin Trials Commun; 2017 Dec; 8():227-233. PubMed ID: 29696213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Trial Comparing Classical Participatory Design to VandAID, an Interactive CrowdSourcing Platform to Facilitate User-centered Design.
    Dufendach KR; Koch S; Unertl KM; Lehmann CU
    Methods Inf Med; 2017 Oct; 56(5):344-349. PubMed ID: 28451689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.
    Schiavone F; Bathia R; Letchemanan K; Masters L; Amos C; Bara A; Brown L; Gilson C; Pugh C; Atako N; Hudson F; Parmar M; Langley R; Kaplan RS; Parker C; Attard G; Clarke NW; Gillessen S; James ND; Maughan T; Sydes MR;
    Trials; 2019 May; 20(1):264. PubMed ID: 31138317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.